Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009
Mon, January 5, 2009
Fri, January 2, 2009
Thu, January 1, 2009
Wed, December 31, 2008
Tue, December 30, 2008
Mon, December 29, 2008
Wed, December 24, 2008
Tue, December 23, 2008
Mon, December 22, 2008
Sun, December 21, 2008
Fri, December 19, 2008
Thu, December 18, 2008

Proteonomix, Inc: Proteonomix, Inc. (PROT) Announces the Appointment of Steven Byle to Its Board of Directors

  Copy link into your clipboard //health-fitness.news-articles.net/content/2009/ .. nt-of-steven-byle-to-its-board-of-directors.html
  Print publication without navigation Published in Health and Fitness on , Last Modified on 2009-01-05 07:09:29 by Market Wire
          🞛 This publication is a summary or evaluation of another publication


MOUNTAINSIDE, NJ--(Marketwire - January 5, 2009) - Proteonomix, Inc. (PINKSHEETS: [ PROT ]) announces the appointment of Steven Byle to its Board of Directors effective January 15, 2009.

Mr. Byle is a successful entrepreneur, engineer and patent attorney with a track record in domestic and international industry. He is presently Vice-President of Technology for Dockwise, B.V., a public, international company with nearly $500 million in annual revenue in the energy industry where he is charge of its R& D program and intellectual property portfolio. He has studied and taught in China and speaks fluent Chinese.

Michael Cohen, CEO of Proteonomix, stated: "We welcome Steven to our board of directors. His extensive background both in intellectual property and corporate development shall enhance our company's growth and development in its commercialization stage."

[ About Proteonomix, Inc. ]

Proteonomix, Inc. is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. It is developing an intellectual property portfolio in the areas of therapeutics and cosmetics. Its research and development program has demonstrated results with more than ten patent applications and multiple products ready to enter their respective markets. Proteonomix has facilities at a number of academic institutions. Its subsidiary, Proteoderm, has developed a line of anti-aging cosmetics. For more information, please visit [ www.proteonomix.com ] or [ www.proteoderm.com ] and [ www.pinksheets.com ].

"Safe Harbor Statement"

Under the Private Securities Litigation Reform Act of 1995, statements herein relating to the Company's expectations are forward-looking statements. The anticipated results, including the entering into an agreement reflecting the terms of the letter of intent and performance pursuance thereto may not occur.



Similar Health and Fitness Publications